πŸ‡ΊπŸ‡Έ FDA
Patent

US 10174302

Modified L-asparaginase

granted A61KA61K38/02A61K38/48

Quick answer

US patent 10174302 (Modified L-asparaginase) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/02, A61K38/48